| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Niagen Bioscience, Inc. | Director | Stock Option (right to buy) | 20K | Jun 24, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NAGE | Niagen Bioscience, Inc. | Jun 24, 2025 | 1 | $0 | 4 | Jun 25, 2025 | Director |
| CDXC | ChromaDex Corp. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| CDXC | ChromaDex Corp. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| CDXC | ChromaDex Corp. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
| CDXC | ChromaDex Corp. | Apr 15, 2022 | 1 | $0 | 4 | Apr 19, 2022 | Director |
| CDXC | ChromaDex Corp. | Apr 15, 2022 | 0 | $0 | 3 | Apr 19, 2022 | Director |